Researchers has developed a generic test for cancer and joined force with a tech company to introduce it to the market.
They are 100% sure this test could be the first screening device to detect cancer.
is a leading causes of death worldwide.
American Institute for Cancer Research says that, there are about 18 million cancer cases diagnosed around the world in 2018 so far and still counting.
The number of new cancer cases per year is expected to reach more than 23 million by 2030.
The most common cancers around the globe are lung cancer, breast cancer, and colorectal cancer.
Lung and breast cancers are 12.3% of the 18 million cases diagnosed in 2018, with more than 2 million cases, respectively. Whiles, Colorectal cancer is in third place with almost 2 million new cases diagnosed in 2018.
Doctors diagnose cancers in several ways. The most common methods include laboratory tests (blood, urine, and others), biopsy, endoscopy, genetic tests, and imaging tests, such as X-ray, MRI, and ultrasound.
Cancer data are alarming, and it is imperative to find new methods to detect cancer in the early stages.
Developing a ‘universal’ blood test
In the past years, researchers at the University of Bradford in the United Kingdom, have focused on a new “universal” blood test for earlier diagnosis of cancer.
They believe that this new test could help detect cancer in people who doctors think may have the disease. The research team partnered with a tech company to bring this revolutionary blood test to market.
This test is different from other universal cancer tests being developed because it is not looking for a specific biomarker or mutation. This is a generic test for cancer in an individual, regardless of the underlying mechanism that’s causing their cancer.”
Lead researcher, Prof. Diana Anderson